Dr. Godwin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Washington Univ Sch of Med
Saint Louis, MO 63101- Is this information wrong?
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 2015 - 2018- University of WashingtonResidency, Internal Medicine, 2012 - 2015
Washington University in St. Louis School of MedicineClass of 2012
Certifications & Licensure
WA State Medical License 2014 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 2 citationsPhase 1/2 Trial of CLAG-M with Dose-Escalated Mitoxantrone in Combination with Fractionated-Dose Gemtuzumab Ozogamicin for Newly Diagnosed Acute Myeloid Leukemia and O...Colin D Godwin, Eduardo Rodríguez-Arbolí, Megan Othus, Anna B Halpern, Jacob S Appelbaum, Mary-Elizabeth M Percival, Paul C Hendrie, Vivian G Oehler, Siobán B Keel, Ja...> ;Cancers. 2022 Jun 14
- 4 citationsTargeting the membrane-proximal C2-set domain of CD33 for improved CD33-directed immunotherapy.Colin D. Godwin, George S. Laszlo, Salvatore Fiorenza, Eliotte E. Garling, Tinh-Doan Phi, Olivia M. Bates, Colin Correnti, Benjamin G. Hoffstrom, Margaret C. Lunn, Oli...> ;Leukemia. 2021 Feb 15
- 6 citationsAcute myeloid leukemia measurable residual disease detection by flow cytometry in peripheral blood vs bone marrow.Colin D Godwin, Yi Zhou, Megan Othus, Mallette M Asmuth, Carole M Shaw, Kelda M Gardner, Brent L Wood, Roland B Walter, Elihu H Estey> ;Blood. 2021 Jan 28
- Join now to see all
Journal Articles
- Relationship Between CD33 Expression, Splicing Polymorphism, and in Vitro Cytotoxicity of Gemtuzumab Ozogamicin and the CD33/CD3 BiTErAMG 330Colin D Godwin, Roland B Walter, Haematologica
Abstracts/Posters
- Additional Cytotoxic Chemotherapy Is Unlikely to Eliminate Measurable Residual Acute Myeloid Leukemia (AML)Colin D. Godwin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Phase 1 Trial of Cladribine, High-Dose Cytarabine, G-CSF, and Dose-Escalated Mitoxantrone (CLAG-M) Plus Gemtuzumab Ozogamicin in Adults with Newly-Diagnosed Acute Myel...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Anti-Apoptotic BCL-2 Family Members Confer Resistance to Calicheamicin-Based Antibody-Drug Conjugate Therapy of Acute Leukemia61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Comparison of Acute Myeloid Leukemia Measurable Residual Disease Detection By Flow Cytometry in Peripheral Blood and Bone Marrow61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Press Mentions
Northwestern Mutual Funds $600,000 in New Grants for Childhood Cancer ResearchOctober 15th, 2018
Hospital Affiliations
UW Medicine/University of Washington Medical CenterSeattle, Washington
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
